Advanced

A Functional Variant in the {alpha}2B Adrenoceptor Gene, a Positional Candidate on Chromosome 2, Associates With Hypertension.

Wowern, Fredrik LU ; Bengtsson Boström, Kristina LU ; Lindblad, Ulf LU ; Råstam, Lennart LU and Melander, Olle LU (2004) In Hypertension 43(592). p.592-597
Abstract
In a genome-wide scan in Scandinavians, we found suggestive linkage between early-onset primary hypertension and a region on chromosome 2. The 2B-adrenoceptor gene, a candidate gene within this region, harbors a functional insertion/deletion (I/D) polymorphism of three glutamate residues. The aim of this study was to investigate

if the DD genotype is associated with hypertension in Swedes. We performed an association study between the I/D

polymorphism of the 2B-adrenoceptor and hypertension in the Skaraborg population. The material consists of all known

patients with primary hypertension in Skara (n772 nondiabetic subjects; n171 normoalbuminuric type 2 diabetic

subjects) and 817 population control... (More)
In a genome-wide scan in Scandinavians, we found suggestive linkage between early-onset primary hypertension and a region on chromosome 2. The 2B-adrenoceptor gene, a candidate gene within this region, harbors a functional insertion/deletion (I/D) polymorphism of three glutamate residues. The aim of this study was to investigate

if the DD genotype is associated with hypertension in Swedes. We performed an association study between the I/D

polymorphism of the 2B-adrenoceptor and hypertension in the Skaraborg population. The material consists of all known

patients with primary hypertension in Skara (n772 nondiabetic subjects; n171 normoalbuminuric type 2 diabetic

subjects) and 817 population control subjects. We first compared genotype frequencies between patients with

early-onset hypertension (aged 50 years or younger at onset) and subjects with normotension (blood pressure

120/80 mm Hg). Thereafter, the polymorphism was tested for association with hypertension at the population level.

When comparing patients with early-onset hypertension and normotensive subjects, the DD versus II genotype was

associated with early-onset hypertension when diabetic subjects were excluded from the analysis (OR2.0; 95%

CI1.2 to 3.5) or when they were not excluded (OR1.8; 95% CI1.0 to 3.1). At the population level, the DD versus

II genotype was weakly associated with nondiabetic hypertension (OR1.4; 95% CI1.0 to 1.8). Our data suggest that carriers of the DD versus II genotype of the 2B-adrenoceptor are at increased risk for hypertension. The genotypic effect is most evident when comparing groups corresponding to the upper and lower tails of the blood pressure distribution in the population; however, in nondiabetic hypertensive subjects it is weakly detectable even at the population level. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
receptors, adrenergic, genetics, hypertension
in
Hypertension
volume
43
issue
592
pages
592 - 597
publisher
Lippincott Williams & Wilkins
external identifiers
  • wos:000189243500014
  • pmid:14744925
  • scopus:1442288386
ISSN
1524-4563
DOI
10.1161/01.HYP.0000116224.51189.80
language
English
LU publication?
yes
id
3b2f7687-32b9-43ed-ac5d-31eb37a4837e (old id 119945)
date added to LUP
2007-07-30 13:24:34
date last changed
2017-04-23 03:39:49
@article{3b2f7687-32b9-43ed-ac5d-31eb37a4837e,
  abstract     = {In a genome-wide scan in Scandinavians, we found suggestive linkage between early-onset primary hypertension and a region on chromosome 2. The 2B-adrenoceptor gene, a candidate gene within this region, harbors a functional insertion/deletion (I/D) polymorphism of three glutamate residues. The aim of this study was to investigate<br/><br>
if the DD genotype is associated with hypertension in Swedes. We performed an association study between the I/D<br/><br>
polymorphism of the 2B-adrenoceptor and hypertension in the Skaraborg population. The material consists of all known<br/><br>
patients with primary hypertension in Skara (n772 nondiabetic subjects; n171 normoalbuminuric type 2 diabetic<br/><br>
subjects) and 817 population control subjects. We first compared genotype frequencies between patients with<br/><br>
early-onset hypertension (aged 50 years or younger at onset) and subjects with normotension (blood pressure<br/><br>
120/80 mm Hg). Thereafter, the polymorphism was tested for association with hypertension at the population level.<br/><br>
When comparing patients with early-onset hypertension and normotensive subjects, the DD versus II genotype was<br/><br>
associated with early-onset hypertension when diabetic subjects were excluded from the analysis (OR2.0; 95%<br/><br>
CI1.2 to 3.5) or when they were not excluded (OR1.8; 95% CI1.0 to 3.1). At the population level, the DD versus<br/><br>
II genotype was weakly associated with nondiabetic hypertension (OR1.4; 95% CI1.0 to 1.8). Our data suggest that carriers of the DD versus II genotype of the 2B-adrenoceptor are at increased risk for hypertension. The genotypic effect is most evident when comparing groups corresponding to the upper and lower tails of the blood pressure distribution in the population; however, in nondiabetic hypertensive subjects it is weakly detectable even at the population level.},
  author       = {Wowern, Fredrik and Bengtsson Boström, Kristina and Lindblad, Ulf and Råstam, Lennart and Melander, Olle},
  issn         = {1524-4563},
  keyword      = {receptors,adrenergic,genetics,hypertension},
  language     = {eng},
  number       = {592},
  pages        = {592--597},
  publisher    = {Lippincott Williams & Wilkins},
  series       = {Hypertension},
  title        = {A Functional Variant in the {alpha}2B Adrenoceptor Gene, a Positional Candidate on Chromosome 2, Associates With Hypertension.},
  url          = {http://dx.doi.org/10.1161/01.HYP.0000116224.51189.80},
  volume       = {43},
  year         = {2004},
}